Harrow Announces Third Quarter 2023 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Tech stocks weigh on Wall Street as Iran stalemate lifts oil, yields
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Wall Street indexes slip as oil prices rise, retail results awaited
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Trump threatens to bomb Oman over Iran stance
- U.S. EV market shows signs of bottoming out: Bernstein
Harrow Health (HROW) Misses Q3 EPS by 15c, Misses on Revenue; Offers FY23 Revenue Guidance
November 13, 2023 4:02 PM ESTHarrow Health (NASDAQ: HROW) reported Q3 EPS of ($0.09), $0.15 worse than the analyst estimate of $0.06. Revenue for the quarter came in at $34.3 million versus the consensus estimate of $37.69 million.
GUIDANCE:
Harrow Health sees FY2023 revenue of $129-136 million, versus the consensus of... More
